Bank of America is set to report fourth-quarter earnings – here’s what to expect

Bank of America is set to report fourth-quarter earnings – here’s what to expect


Brian Moynihan, Chairman and CEO of Bank of America, speaks with Economic Club of Washington Chair David Rubenstein at an event at the Ritz-Carlton on February 25, 2025 in Washington, DC.

Anna Moneymaker | Getty Images

Bank of America is scheduled to report fourth-quarter earnings before the opening bell Wednesday.

Here’s what Wall Street expects:

  • Earnings: 96 cents a share, according to LSEG
  • Revenue: $27.94 billion, according to LSEG
  • Net interest income: $15.68 billion, according to StreetAccount
  • Trading: Fixed Income of $2.64 billion, equities of $1.86 billion, according to StreetAccount

Bank of America, the second-largest U.S. bank by assets, has been a beneficiary of the industry’s recent tailwinds.

Surging Wall Street trading and advisory fees, stable consumer credit and deregulation have all helped the lender, whose shares rose 24% last year.

Analysts will want to hear guidance from CEO Brian Moynihan as to whether momentum will carry into 2026.

On Tuesday, JPMorgan Chase posted results that exceeded expectations on better-than-expected trading revenue. Citigroup and Wells Fargo also report results Wednesday, while Goldman Sachs and Morgan Stanley are releasing results Thursday.

This story is developing. Please check back for updates.



Source

Inside the booming business of wellness third spaces and membership clubs
Business

Inside the booming business of wellness third spaces and membership clubs

A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn’t have to involve alcohol. Newly sober and surrounded by friends who also chose not to drink, Guo said she wanted alternatives to the typical social scene. After some research, she landed on Bathhouse and Othership: […]

Read More
FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More